Follow
Valerie Chew
Valerie Chew
Translational Immunology Institute (TII)
Verified email at duke-nus.edu.sg - Homepage
Title
Cited by
Cited by
Year
Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma
M Garnelo, A Tan, Z Her, J Yeong, CJ Lim, J Chen, KH Lim, A Weber, ...
Gut 66 (2), 342-351, 2017
3292017
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
V Chew, J Chen, D Lee, E Loh, J Lee, KH Lim, A Weber, K Slankamenac, ...
Gut 61 (3), 427-438, 2012
3282012
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
V Chew, C Tow, M Teo, HL Wong, J Chan, A Gehring, M Loh, A Bolze, ...
Journal of hepatology 52 (3), 370-379, 2010
2752010
Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
CJ Lim, YH Lee, L Pan, L Lai, C Chua, M Wasser, TKH Lim, J Yeong, ...
Gut 68 (5), 916-927, 2019
1822019
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
V Chew, L Lai, L Pan, CJ Lim, J Li, R Ong, C Chua, JY Leong, KH Lim, ...
Proceedings of the National Academy of Sciences 114 (29), E5900-E5909, 2017
1672017
Immune microenvironment in tumor progression: characteristics and challenges for therapy
V Chew, HC Toh, JP Abastado
Journal of oncology 2012, 2012
1612012
Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma
V Chew, YH Lee, L Pan, NJM Nasir, CJ Lim, C Chua, L Lai, SN Hazirah, ...
Gut 68 (2), 335-346, 2019
1442019
PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity
TS Lim, V Chew, JL Sieow, S Goh, JPS Yeong, AL Soon, ...
Oncoimmunology 5 (3), e1085146, 2016
1442016
Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model
EA Bard-Chapeau, AT Nguyen, AG Rust, A Sayadi, P Lee, BQ Chua, ...
Nature genetics 46 (1), 24-32, 2014
1112014
Toll-like receptor 3 expressing tumor parenchyma and infiltrating natural killer cells in hepatocellular carcinoma patients
V Chew, C Tow, C Huang, E Bard-Chapeau, NG Copeland, NA Jenkins, ...
JNCI: Journal of the National Cancer Institute 104 (23), 1796-1807, 2012
942012
Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma
PHD Nguyen, S Ma, CZJ Phua, NA Kaya, HLH Lai, CJ Lim, JQ Lim, ...
Nature communications 12 (1), 227, 2021
702021
TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
V Ho, TS Lim, J Lee, J Steinberg, R Szmyd, M Tham, J Yaligar, P Kaldis, ...
Oncotarget 6 (29), 27252, 2015
682015
Combinational immunotherapy for hepatocellular carcinoma: radiotherapy, immune checkpoint blockade and beyond
YH Lee, D Tai, C Yip, SP Choo, V Chew
Frontiers in Immunology 11, 568759, 2020
642020
An automated staining protocol for seven-colour immunofluorescence of human tissue sections for diagnostic and prognostic use
JCT Lim, JPS Yeong, CJ Lim, CCH Ong, SC Wong, VSP Chew, ...
Pathology 50 (3), 333-341, 2018
542018
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
HHM Ng, RY Lee, S Goh, ISY Tay, X Lim, B Lee, V Chew, H Li, B Tan, ...
Journal for immunotherapy of cancer 8 (2), 2020
492020
Expression of CD38 on macrophages predicts improved prognosis in hepatocellular carcinoma
JH Lam, HHM Ng, CJ Lim, XN Sim, F Malavasi, H Li, JJH Loh, K Sabai, ...
Frontiers in immunology, 2093, 2019
412019
High-dimensional immune-profiling in cancer: implications for immunotherapy
S Chuah, V Chew
Journal for immunotherapy of cancer 8 (1), 2020
392020
Leupaxin negatively regulates B cell receptor signaling
V Chew, KP Lam
Journal of Biological Chemistry 282 (37), 27181-27191, 2007
342007
Rationale of immunotherapy in hepatocellular carcinoma and its potential biomarkers
D Tai, SP Choo, V Chew
Cancers 11 (12), 1926, 2019
282019
Immunomodulation of the tumor microenvironment by Toll-like receptor-3 (TLR3) ligands
V Chew, JP Abastado
Oncoimmunology 2 (4), e23493, 2013
282013
The system can't perform the operation now. Try again later.
Articles 1–20